Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.

about

Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.

Item

http://www.wikidata.org/entity/Q41527939

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Choice of New Oral Anticoagula ...... Fibrillation: FANTASIIA Study.

@en

type

Item

label

Choice of New Oral Anticoagula ...... Fibrillation: FANTASIIA Study.

@en

prefLabel

Choice of New Oral Anticoagula ...... Fibrillation: FANTASIIA Study.

@en

P1476

Choice of New Oral Anticoagula ...... Fibrillation: FANTASIIA Study.

@en

P2093

Inmaculada Roldán

http://www.w3.org/2001/XMLSchema#string

Javier Muñiz

http://www.w3.org/2001/XMLSchema#string

Jesús Castillo

http://www.w3.org/2001/XMLSchema#string

Juan Sanchis

http://www.w3.org/2001/XMLSchema#string

Manuel Anguita-Sanchez

http://www.w3.org/2001/XMLSchema#string

investigators of the FANTASIIA study

http://www.w3.org/2001/XMLSchema#string

Ángel Cequier

http://www.w3.org/2001/XMLSchema#string

P2860

Atrial fibrillation and stroke prevention

Dabigatran versus warfarin in patients with atrial fibrillation

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.

Risk factors for nonadherence to warfarin: results from the IN-RANGE study.

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

P304

150-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1074248415596426

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vicente Bertomeu-González

José Moreno-Arribas

Vicente Bertomeu Martínez

Francisco Marín

P577

2015-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26229096

http://www.w3.org/2001/XMLSchema#string

P921

vitamin K

anticoagulation